will try to use only the details needed to define the present status of the studies and the main questions that must be answered if they are to become useful for mutagenesis detection in human cells.
Human Cells for Mutation Studies
Cultures of skin fibroblasts that are usable for mutation studies can Life span is still an ineluctable limitation, which just hasn't prevented us and others (5, 6 ) from making progress in the study of mutation. The number of doublings allotted to fibroblasts in vitro is usually estimated at 50-60. Only about 20 doublings are used when a single mutant cell generates 108 progeny, enough cells for karyotype analysis, quantitative growth studies and sensitive enzyme determinations. This often leaves many doublings that can be used to generate large cell populations for partial enzyme purification or other chemical determinations and for genetic experimentation, such as subcloning in the absence of selective agents, selection for revertants and somatic cell hybridization. These comments should not be interpreted as special pleading for the adoption of human fibroblasts as the subject for mutagenesis testing. My basic attitude is that fibroblasts are the closest convenient approximations to normal cultured human cells that are currently available. They should be used for what they can provide in the way of raw materials for developing mutagenesis methods and as one standard of realism to be used in evaluating the results that are obtained with the methods. I will make a few comments about fibroblasts in relation to other mammalian cells after I have described some genetic results.
Resistance to 8-Azaguanine
Hereditary cell variants that are resistant to 8-azaguanine (AG) can be detected in fibroblast cultures derived from apparently any human, male or female. The average incidence of AG-resistant (AGr) clones is about 5 x 10-6 (2) . A simple principle is applied in detecting the mutants. AG, as such, is innocuous to cells at 10-6-10-4M concentration but is converted to a toxic monoribonucleotide by the enzyme HG-PRT in normal cells (Fig. 1 (1) a mutation in an X-chromosomal gene that reduced HG-PRT activity but not enough to, by itself, reduce the production of AG-nucleotide to sub-toxic amounts; (2) the overproduction of purines by the de novo pathway, which occurs in cells from HG-PRT-deficient humans. The excess normal nucleotides might minimize the effects of AG-nucleotide. If genes necessary for the overproduction are located on autosomes two relevant types of clones may segregate out of H [AS] -selected hybrids: clones retaining only the human X, which are either sensitive or slightly resistant to AG but whose HG-PRT may, nevertheless, be demonstrably abnormal; AG-resistant clones retaining the human X and at least one other, specific, human chromosome.
If AG resistance resulted from the transdominant effect of an autosomal mutation on a normal X-chromosomal HG-PRT locus then, again, two types of clones might segregate from H [AS] -selected hybrids: AGsensitive clones retaining only the human X and producing qualitatively and quantitatively normal human HG-PRT; AGresistant clones that retain the human X and at least one other, specific, human chromosome. HG-PRT activity would be reduced but qualitatively normal.
Other genetic bases for AG resistance are conceivable but will not be discussed. My object is simply to emphasize that it will be possible to attempt a genetic analysis of the commonest type of AGr mutants of human fibroblasts. Three crosses with independent Type II mutants are in progress. One was performed with cells from the human prototype of Type II mutants, which I mentioned above. In this case, we know that the HG-PRT is qualitatively altered as the result of a mutation in an X-chromosomal gene (2) . Therefore, the properties of hybrids obtained with this mutant will provide a standard for evaluating the results obtained with in vitro mutants. Furthermore, the AG resistance and HG-PRT activity of these hybrids can be compared with If an adequately firm genetic foundation for AG-resistant mutations in human cells can be laid down, additional information will be needed to make them useful for mutagenesis testing. First, we should determine that the mutation-detection method is responsive to known mutagens. Some information is available but more is needed. There is published evidence that x-rays increase the rate of mutation to AG resistance (3) and evidence, to be published, that MNNG has spectacular mutagenic effects (7) . Second, more reliable and representative estimates of the rate of spontaneous mutation are needed, since this is the most useful standard for quantitatively evaluating mutagenic effects, especially small ones. These estimates are best derived from fluctuation tests, some repeated, with cultures from a number of humans of different sexes and races.
Resistance to 2,6-Diaminopurine
The preceding discussion makes possible a concise description of a second selection system, which Dr. Harriet Rappaport and I have recently been studying with human cells (4 The need for information about the ingen.
cidences of mutant somatic cells in vivo inOne problem associated with direct test-troduces the second difficulty with direct testing is the cumulative incidence of mutants ing: deciding if a cell with a specific abnorthat results from their proliferation after mal phenotype is a genetic variant or a phethey originate in a population of dividing nocopy. Mostly histochemical, serological, or cells. This is the background above which other methods that kill individual cells in mutagenic effects must be detected in vivo. the process of defining their phenotypes will Its magnitude can be roughly. evaluated by be u-sed in direct testing. We will need backusing information that is available now and ground genetic information, which will give the assumption that mutation rates-are sim-' us confidence that a cell with a specific ab- The serious technical limitation called "metabolic cooperation" (9) afflicts the AGresistance selection system and, probably, the DAP-resistance selection system as used with human fibroblasts and Chinese hamster cells: AGr mutants become AG-sensitive phenocopies as a result of contact with normal cells in the presence of AG. Maximum recovery of mutants for purposes of quantitation requires that selection be applied to populations less dense than about 60 cells/ mm2 of surface. This requirement causes experiments to be larger and more expensive than is desirable. To me, the cost-benefit ratio will still be small if application of these methods prevents the dissemination of just one weak mutagen. Nevertheless, elimination of the complication created by metabolic cooperation from these selection systems or others should be an important objective of future investigation.
Metabolic cooperation may be insignificant in cultures of human lymphoblastoid cells and mouse lymphoma cells. Some cultures of lymphoblastoid cells have high cloning efficiencies and can be propagated without limit in vitro. The mouse lymphoma cells have the added advantage of being unhampered by major histocompatibility barriers in hostmediated applications. Both types of cells may have much to offer in mutagenicity testing. At this time, lymphoblastoid lines exhibit great variability in cloning efficiencies and in sensitivities to the lethal and mutagenic effects of chemical mutagens (10) . Their indefinitely prolonged in vitro propagability may depend on the presence of a viral (Epstein-Barr) genome, which might conceivably affect the mutational behavior of the cells. Nevertheless, human lymphoblastoid cells, mouse lymphoma cells, Chinese hamster cells and, perhaps, others, are potential substitutes for human fibroblasts. It would be important in some applications to show that their mutation mechanisms and mutagenic responsiveness are representative of normal human cells. They should not be markedly hyper-or hyporesponsive in comparison to normal cells, but the latter is the more dangerous difference. The only way this can be determined is by a detailed comparison of fibroblast strains and other cell lines with regard to mutagenic responsiveness at several loci. A comparison of DNA repair mechanisms should be a part of such studies. Finally, it will be of considerable in-terest to determine if lymphoblasts and fibroblasts from the same person exhibit similar mutational behavior.
